| Checkpoint inhibitors in the treatment of urological malignancies LS Popovic, G Matovina-Brko, M Popovic ESMO open 2 (2), e000165, 2017 | 26 | 2017 |
| COVID-19 vaccines and cancer patients: acceptance, attitudes and safety GM Brko, M Popovic, M Jovic, J Radic, MB Kladar, I Nikolic, V Vidovic, ... J. BUON 26 (5), 2183-2190, 2021 | 25 | 2021 |
| Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma M Popovic, G Matovina-Brko, M Jovic, LS Popovic World Journal of Clinical Oncology 13 (1), 28, 2022 | 15 | 2022 |
| Immunotherapy in the treatment of lymphoma LS Popovic, G Matovina-Brko, M Popovic, M Popovic, A Cvetanovic, ... World Journal of Stem Cells 13 (6), 503, 2021 | 6 | 2021 |
| Prognostic value of Age-Adjusted International Prognostic Index in patients with relapsed or refractory Diffuse Large B-Cell Lymphoma-a single centre experience M Popović, G Matovina-Brko, D Petrović, B Vranjković, J Radić, L Popović Medicinski pregled 72 (1-2), 25-29, 2019 | 2 | 2019 |
| Optimal time for adjuvant therapy initiation in breast cancer patients: A single center experience B Vranjković, D Petrović, J Radić, M Popović, KI Bjelobrk, N Petrović Medicinski pregled 71 (11-12), 394-403, 2018 | 1 | 2018 |
| Real world data: Trastuzumab w/o concurrent endocrine therapy in luminal HER2-positive metastatic breast cancer resulted in decreased overall survival S Susnjar, L Popovic, A Cvetanovic, N Stanic, J Citic, I Kolarov-Bjelobrk, ... European Journal of Cancer 92, S112, 2018 | | 2018 |
